Tipifarnib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Clinical trial NCT02227901 · COMPLETED
Trial details
- NCT number
- NCT02227901
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2002-09-01
- Primary completion
- 2007-06-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.